That’s not overhyping.. that’s giving reference and guidance to similar deals in the same medical space.
I’d rather have a CEO and president that’s excited about their company and potential drugs. Show me CEO’s that don’t show optimism about their drugs in the pipeline.. Maybe read a few quarterly reports and listen to a few conference calls. They all do it.
One successful trial and all this overhyping rhetoric goes away. Leo quickly becomes validated for his enthusiasm and all the work his team has has accomplished over the years.
News 
Market Data 
Discover 
AI
